Home › PAREXEL Expands Model-Based Drug Development Offering
 

Keywords :   


PAREXEL Expands Model-Based Drug Development Offering

2015-07-10 05:41:00| drugdiscoveryonline News Articles

PAREXEL International Corporation, a leading global biopharmaceutical services provider, recently announced expanded services and capabilities in model-based drug development (MBDD) through their Quantitative Clinical Development (QCD) group.

Tags: development drug offering expands

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »